| Issue Date | Title | Author(s) |
| 2024 | Approaches to therapy Amlodipine/Indapamide/ Perindopril therapy of high arterial hypertension in ischemic heart disease patients with chronic kidney disease stage 1-3 after coronary stenting | Pribylov, S. A.; Leonidova, K. O.; Pribylov, V. S.; Gavrilyuk, E. V.; Pribylova, N. N. |
| 2018 | Clinical and genetic study of chronic kidney disease | Nekipelova, E. V.; Novakova, O. N.; Kulikovskij, V. F.; Zhernakova, N. I.; Churnosov, M. I. |
| 2018 | Genetic factors of renal survival in patents with chronic kidney disease | Nekipelova, E. V.; Novakova, O. N.; Yakunchenko, T. I.; Efremova, O. A.; Kulikovskiy, V. F. |
| 2014 | Polimorphism of vascular homeostasis genes and progression of chronic kidney disease in patients with chronic glomerulonephritis | Litovkina, O. N.; Nekipelova, E. V.; Sirotina, S. S.; Yakunchenko, T. I.; Efremova, O. A.; Sorokina, I. N. |
| 2019 | Renoprotective effects of 3 HMG reductase blockers in elderly patients with acute coronary syndrome undergoing revascularization through percutaneous coronary intervention | Osipova, O. A.; Zhernakova, N. I.; Dobromirova, E. V.; Golovin, A. I. |
| 2026 | The effect of methylethylpyridinol hydrochloride on the levels of α-tocopherol and transforming growth factor β-1 in patients with chronic kidney disease and type 2 diabetes mellitus | Anufrieva, E. I.; Popov, S. S.; Krylskii, E. D.; Verevkin, A. N.; Bolotskih, V. I.; Sviridov, D. V. |
| 2026 | The impact of fixed-dose anatihypertensive therapy on cardiorenal syndrome markers in patients with acute coronary syndrome and comorbidities | Pribylov, S. A.; Leonidova, K. O.; Pribylov, V. S.; Gavrilyuk, E. V.; Pribylova, N. N. |
| 2018 | The relationship of molecular-genetic markers of chemokines with clinical manifestations of chronic kidney disease | Nekipelova, E. V.; Novakova, O. N.; Yakunchenko, T. I.; Churnosov, M. I.; Zhernakova, N. I. |
